Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 12/11/2019
SIETES contiene 92833 citas

 
 
<< anterior 21 a 40 de 54 siguiente >>
Presentar resultados
Seleccionar todas
21. Cita con resumen
22. Cita con resumen
Ludlam CA, Powderly WG, Bozzette S, Diamond M, Koerper MA, Kulkarni R, Ritchie B, Siegel J, Simmonds P, Stanley S, Tapper ML, von Depka M. Clinical perspectives of emerging pathogens in bleeding disorders. Lancet 2006;367:252-61. [Ref.ID 76000]
24. Cita con resumen
Anónimo. Bayer pharma pins turnaround hopes on two products. Scrip 2005;3038:10. [Ref.ID 73180]
25. Cita con resumen
Sukkar E. Should the NHS pay for expensive medicines for very rare diseases?. Scrip 2005;3028:6. [Ref.ID 72866]
26.
Haj M, Dasani H, Kundu S, Mohite U, Collins PW. Acquired haemophilia A may be associated with clopidogrel. BMJ 2004;329:323. [Ref.ID 71077]
27.
Anónimo. Novoseven for non-hemophilia hemostasis. Med Lett Drugs Ther 2004;46:33-4. [Ref.ID 70095]
28.
Anónimo. Moroctocog alfa. Reports of lack of effect in prophylaxis patients. Canada. WHO Pharmaceuticals Newsletter 2003;5:2. [Ref.ID 68089]
29.Tiene citas relacionadas
Guttmacher AE, Collins FS. Welcome to the genomic era. N Engl J Med 2003;349:996-8. [Ref.ID 67307]
30.Tiene citas relacionadas
Burke W. Genomics as a probe for disease biology. N Engl J Med 2003;349:969-74. [Ref.ID 67305]
31.
Petrini P. Treatment strategies in children with hemophilia. Pediatr Drugs 2002;4:427-37. [Ref.ID 62721]
32.
Santagostino E, Gringeri A, Mannucci PM. State of care for hemophilia in pediatric patients. Pediatr Drugs 2002;4:149-57. [Ref.ID 61441]
33.
Björkman S, Berntorp E. Pharmacokinetics of coagulation factors: clinical relevance for patients with haemophilia. Clin Pharmacokinet 2001;40:815-32. [Ref.ID 59364]
34. Cita con resumen
Anónimo. CPMP wants more trials on BeneFix. Scrip 2001;2685:22. [Ref.ID 58139]
35.
Gottlieb S. Gene therapy shows promise for haemophilia. BMJ 2001;322:1442. [Ref.ID 57013]
36.Tiene citas relacionadas
Mannucci PM, Tudenham EGD. The hemophilias - from royal genes to gene therapy. N Engl J Med 2001;344:1773-9. [Ref.ID 56867]
37.Tiene citas relacionadas
Miller DG, Stamatoyannopoulos G. Gene therapy for hemophilia. N Engl J Med 2001;344:1782-4. [Ref.ID 56857]
38.Tiene citas relacionadas Cita con resumen
Roth D A, Tawa NE, O'Brien JM, Treco D A, Selden RF, for the Factor VIII Transkaryotic Therapy Study Group. Nonviral transfer of the gene encoding coagulation factor VIII in patients with severe hemophilia A. N Engl J Med 2001;344:1735-42. [Ref.ID 56853]
39.
High KA. Gene therapy in haematology and oncology. Lancet 2000;356:8. [Ref.ID 54170]
40.
Ho AYL, Height SE, Smith MP. Immune tolerance therapy for haemophilia. Drugs 2000;60:547-54. [Ref.ID 53891]
Seleccionar todas
 
<< anterior 21 a 40 de 54 siguiente >>